Value of early metabolic response for predicting axillary pathological complete response during neoadjuvant systemic therapy in triple negative and HER2-amplified breast cancers: impact of tumor subtypes
Delta Axillary SUVmax seems to be the most relevant metabolic parameter to predict an axillary pathological complete response and early metabolic response could be a valuable tool for selecting patients eligible for axillary surgical de-escalation after NST, regardless tumor subtypes.
Authors
- Pedro Nunes
- Eloïse Michel
- Clémentine Jankowski (ORCID: https://orcid.org/0000-0002-0152-8101)
- Sylvain Ladoire (ORCID: https://orcid.org/0000-0002-0331-9194)
- Aurélie Bertaut (ORCID: https://orcid.org/0000-0002-7934-9509)
- Alexandre Cochet (ORCID: https://orcid.org/0009-0003-1747-8035)
- Charles Coutant (ORCID: https://orcid.org/0000-0003-4355-7012)
- Jean‐Louis Alberini (ORCID: https://orcid.org/0000-0001-5618-1646)
- Loup Guichard
Institutions
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Centre Georges François Leclerc (FR)
Publication Details
- Journal
- Cancer Imaging
- Published
- 2025-09-24
- DOI
- https://doi.org/10.1186/s40644-025-00914-9
- Citations
- 1
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.94